| Antidepressant and antipsychotic activity of new quinoline-and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors P Zajdel, K Marciniec, A Maślankiewicz, K Grychowska, G Satała, ... European Journal of Medicinal Chemistry 60, 42-50, 2013 | 93 | 2013 |
| Quinoline-and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents? P Zajdel, A Partyka, K Marciniec, AJ Bojarski, M Pawlowski, ... Future medicinal chemistry 6 (1), 57-75, 2014 | 90 | 2014 |
| Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity W Deraredj Nadim, S Chaumont-Dubel, F Madouri, L Cobret, ... Proceedings of the National Academy of Sciences 113 (43), 12310-12315, 2016 | 87 | 2016 |
| Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with … K Grychowska, G Satała, T Kos, A Partyka, E Colacino, ... ACS Chemical Neuroscience 7 (7), 972-983, 2016 | 79 | 2016 |
| Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases D Vanda, P Zajdel, M Soural European Journal of Medicinal Chemistry 181, 111569, 2019 | 72 | 2019 |
| Quinoline-and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation P Zajdel, K Marciniec, A Maślankiewicz, G Satała, B Duszyńska, ... Bioorganic & medicinal chemistry 20 (4), 1545-1556, 2012 | 65 | 2012 |
| Separation and characterization of ciprofloxacin, difloxacin, lomefloxacin, norfloxacin, and ofloxacin oxidation products under potassium permanganate treatment in acidic … U Hubicka, P Żmudzki, B Żuromska-Witek, P Zajdel, M Pawłowski, J Krzek Talanta 109, 91-100, 2013 | 55 | 2013 |
| Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects P Zajdel, T Kos, K Marciniec, G Satała, V Canale, K Kamiński, M Hołuj, ... European Journal of Medicinal Chemistry 145, 790-804, 2018 | 47 | 2018 |
| N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties P Zajdel, K Marciniec, G Satała, V Canale, T Kos, A Partyka, ... ACS Medicinal Chemistry Letters 7 (6), 618-622, 2016 | 47 | 2016 |
| The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl-and arylthioethyl-piperidines and pyrrolidines as a novel … P Zajdel, R Kurczab, K Grychowska, G Satała, M Pawłowski, AJ Bojarski European journal of medicinal chemistry 56, 348-360, 2012 | 47 | 2012 |
| Arene-and quinoline-sulfonamides as novel 5-HT7 receptor ligands P Zajdel, K Marciniec, A Maślankiewicz, MH Paluchowska, G Satała, ... Bioorganic & medicinal chemistry 19 (22), 6750-6759, 2011 | 44 | 2011 |
| Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo [4, 5-b] pyridines with cognition enhancing properties D Vanda, M Soural, V Canale, S Chaumont-Dubel, G Satała, T Kos, ... European Journal of Medicinal Chemistry 144, 716-729, 2018 | 43 | 2018 |
| Novel class of arylpiperazines containing N-acylated amino acids: Their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation P Zajdel, G Subra, AJ Bojarski, B Duszyńska, E Tatarczyńska, A Nikiforuk, ... Bioorganic & medicinal chemistry 15 (8), 2907-2919, 2007 | 40 | 2007 |
| A New Class of Arylpiperazine Derivatives: the Library Synthesis on SynPhase Lanterns and Biological Evaluation on Serotonin 5-HT1A and 5-HT2A Receptors P Zajdel, G Subra, AJ Bojarski, B Duszyńska, M Pawłowski, J Martinez Journal of Combinatorial Chemistry 6 (5), 761-767, 2004 | 40 | 2004 |
| Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy) ethyl-alkyl amines: multiobjective based design, synthesis, and antidepressant and anxiolytic … V Canale, R Kurczab, A Partyka, G Satała, T Lenda, ... European journal of medicinal chemistry 108, 334-346, 2016 | 39 | 2016 |
| From haloquinolines and halopyridines to quinoline-and pyridinesulfonyl chlorides and sulfonamides A Maslankiewicz, K Marciniec, M Pawlowski, P Zajdel Heterocycles 71 (9), 1975-1990, 2007 | 39 | 2007 |
| New Arylpiperazine 5-HT1A Receptor Ligands Containing the Pyrimido[2,1-f]purine Fragment: Synthesis, in Vitro, and in Vivo Pharmacological Evaluation S Jurczyk, M Kołaczkowski, E Maryniak, P Zajdel, M Pawłowski, ... Journal of medicinal chemistry 47 (10), 2659-2666, 2004 | 39 | 2004 |
| Amino Acid Hot Spots of Halogen Bonding: A Combined Theoretical and Experimental Case Study of the 5-HT7 Receptor R Kurczab, V Canale, G Satała, P Zajdel, AJ Bojarski Journal of Medicinal Chemistry 61 (19), 8717-8733, 2018 | 34 | 2018 |
| Ergotamine and nicergoline—facts and myths P Zajdel, M Bednarski, J Sapa, G Nowak Pharmacological Reports 67, 360-363, 2015 | 34 | 2015 |
| Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties J Staroń, R Kurczab, D Warszycki, G Satała, M Krawczyk, R Bugno, ... European Journal of Medicinal Chemistry 185, 111857, 2020 | 32 | 2020 |
Andrzej BojarskiMaj Institute of Pharmacology Polish Academy of Sciences在 if-pan.krakow.pl 的电子邮件经过验证
